[HTML][HTML] Pulmonary inflammatory response in lethal COVID-19 reveals potential therapeutic targets and drugs in phases III/IV clinical trials
Background: It is imperative to identify drugs that allow treating symptoms of severe COVID-
19. Respiratory failure is the main cause of death in severe COVID-19 patients, and the host …
19. Respiratory failure is the main cause of death in severe COVID-19 patients, and the host …
[HTML][HTML] Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials
A López-Cortés, S Guerrero, E Ortiz-Prado… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Background: It is imperative to identify drugs that allow treating symptoms of severe COVID-
19. Respiratory failure is the main cause of death in severe COVID-19 patients, and the host …
19. Respiratory failure is the main cause of death in severe COVID-19 patients, and the host …
[PDF][PDF] Pulmonary Inflammatory Response in Lethal
A López-Cortés, S Guerrero, E Ortiz-Prado… - 2022 - researchgate.net
Background: It is imperative to identify drugs that allow treating symptoms of severe COVID-
19. Respiratory failure is the main cause of death in severe COVID-19 patients, and the host …
19. Respiratory failure is the main cause of death in severe COVID-19 patients, and the host …
[PDF][PDF] Pulmonary Inflammatory Response in Lethal
A López-Cortés, S Guerrero, E Ortiz-Prado… - 2022 - scienceopen.com
Background: It is imperative to identify drugs that allow treating symptoms of severe COVID-
19. Respiratory failure is the main cause of death in severe COVID-19 patients, and the host …
19. Respiratory failure is the main cause of death in severe COVID-19 patients, and the host …
Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials.
A López-Cortés, S Guerrero, E Ortiz-Prado… - Frontiers in …, 2022 - europepmc.org
Background: It is imperative to identify drugs that allow treating symptoms of severe COVID-
19. Respiratory failure is the main cause of death in severe COVID-19 patients, and the host …
19. Respiratory failure is the main cause of death in severe COVID-19 patients, and the host …
Pulmonary inflammatory response in lethal COVID-19 reveals potential therapeutic targets and drugs in phases III/IV clinical trials.
A López-Cortés, S Guerrero, E Ortiz-Prado… - 2022 - cabidigitallibrary.org
Background: It is imperative to identify drugs that allow treating symptoms of severe COVID-
19. Respiratory failure is the main cause of death in severe COVID-19 patients, and the host …
19. Respiratory failure is the main cause of death in severe COVID-19 patients, and the host …
[HTML][HTML] Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials
A López-Cortés, S Guerrero, E Ortiz-Prado… - Frontiers in …, 2022 - frontiersin.org
Background: It is imperative to identify drugs that allow treating symptoms of severe COVID-
19. Respiratory failure is the main cause of death in severe COVID-19 patients, and the host …
19. Respiratory failure is the main cause of death in severe COVID-19 patients, and the host …
Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials
A López-Cortés, S Guerrero… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Background: It is imperative to identify drugs that allow treating symptoms of severe COVID-
19. Respiratory failure is the main cause of death in severe COVID-19 patients, and the host …
19. Respiratory failure is the main cause of death in severe COVID-19 patients, and the host …
Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials
A López Cortés, S Guerrero, E Ortiz Prado, V Yumiceba… - 2022 - repositorio.ikiam.edu.ec
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent of
the coronavirus disease 2019 (COVID-19), has led to more than 425 million cases and more …
the coronavirus disease 2019 (COVID-19), has led to more than 425 million cases and more …
Pulmonary inflammatory response in lethal COVID-19 reveals potential therapeutic targets and drugs in phases III/IV clinical trials
A López Cortés, S Guerrero, E Ortiz Prado, V Yumiceba… - 2022 - repositorio.uchile.cl
Background: It is imperative to identify drugs that allow treating symptoms of severe COVID-
19. Respiratory failure is the main cause of death in severe COVID-19 patients, and the host …
19. Respiratory failure is the main cause of death in severe COVID-19 patients, and the host …